A Dow Jones Newswires story covers personalized medicine with profiles of companies, including Sequenom and Helicos, that push diagnostic tests for biomarkers. It's the expected growth in this arena that led to Invitrogen's $6.7 billion acquisition of Applied Biosystems, the article says; more deals are likely in the offing. The story quotes analyst Arthur Henderson as saying, "There is a lot of competition for deals; it is going to increase. ... The sky is the limit in terms of opportunity."

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.